<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Cook Medical News</title><link>http://www.cookmedical.com/newsroom.do</link><description>Cook Medical News Releases</description><language>en_US</language><copyright>Copyright Cook Medical 2010</copyright><webMaster>webmaster@cook-inc.com</webMaster><pubDate>Thu, 9 Sep 2010 00:00:00 EDT</pubDate><generator>jRSSGenerator by Henrique A. Viecili</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><image><url>http://www.cookmedical.com/img/favicon.gif</url><title>Cook Medical News</title><link>http://www.cookmedical.com</link><width>88</width><height>31</height></image><item><title>Cook Medical Appoints New China General Manager</title><link>http://www.cookmedical.com/newsDetail.do?id=6605</link><description>Shanghai, China, September 9, 2010 &amp;#8212; Cook Medical, one of the leading developers of healthcare devices, today announced the appointment of Ms. Rebecca Liu as its new General Manager of China. </description><author>David McCarty</author><pubDate>Thu, 9 Sep 2010 00:00:00 EDT</pubDate></item><item><title>CE Mark Approval of New Five-Lumen Spectrum Catheter Reduces Risk of Deadly Infections in European Patients</title><link>http://www.cookmedical.com/newsDetail.do?id=6604</link><description>Limerick, Ireland, August 23, 2010 &amp;#8212; With the addition of the new five&amp;#45;lumen central venous catheter (CVC), Cook Medical now provides a full line of Spectrum technology products for physicians and patients in Europe. The five&amp;#45;lumen CVC was created in response to physician demand and provides ease and convenience to health&amp;#45;care centers, providing Spectrum multi&amp;#45;lumen catheter technology needed in the most demanding critical care cases.</description><author>Marsha Lovejoy</author><pubDate>Mon, 23 Aug 2010 00:00:00 EDT</pubDate></item><item><title>Bill Cook receives Pioneer Award from Pediatric and Adult Interventional Cardiac Symposium</title><link>http://www.cookmedical.com/newsDetail.do?id=6505</link><description>Bloomington, Ind., August 2, 2010 &amp;#8211; Cook Medical is proud to announce that its founder, Bill Cook, recently received the Pioneer Award from the Pediatric and Adult Interventional Cardiology Symposium &amp;#40;PICS&amp;#45;AICS&amp;#41;. The Pioneer Award is the organization&amp;#39;s most prestigious award and has been given out only once before in the organization&amp;#39;s history. The award honors an individual who has contributed in a significant way to pediatric interventional cardiology.</description><author>Caitlin Wenz</author><pubDate>Mon, 2 Aug 2010 00:00:00 EDT</pubDate></item><item><title>Multiple Studies Show that Cook Medical BIGopsy Backloading Biopsy Forceps Can Aid in Proper Cancer Diagnosis</title><link>http://www.cookmedical.com/newsDetail.do?id=6504</link><description>San Francisco, CA &amp;#8211; July 20, 2010 &amp;#8212; Two independent clinical studies show that Cook Medical&amp;#39;s BIGopsy&amp;#174; Backloading Biopsy Forceps&amp;#39; ability to obtain larger tissue samples for biopsy can lead to an improved ability to diagnose the cause of suspicious ureteral or kidney lesions. The results of both studies were presented separately at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.</description><author>Gail McDaniel</author><pubDate>Tue, 20 Jul 2010 00:00:00 EDT</pubDate></item><item><title>One&amp;#45;Stop, Online Resource for Assisted Reproductive Technology Expands Access to Dynamic Educational Content</title><link>http://www.cookmedical.com/newsDetail.do?id=6405</link><description>Bloomington, Ind. &amp;#8211; July 6, 2010 &amp;#8211; Coming on the heels of CookARTLab.com&amp;#39;s first anniversary, Cook Medical has introduced CookARTLab.com version 2.0, the newest edition of its website focused on assisted reproductive technology &amp;#40;A.R.T.&amp;#41;. The upgraded site now offers improved user functionality, new educational resources and easier homepage access to Cook&amp;#39;s featured A.R.T. products. In the site&amp;#39;s first year alone, CookARTLab.com hosted 21,637 visitors from 100 countries around the world. Forty&amp;#45;six percent were return visitors, with eleven percent coming back to the site more than 200 times.</description><author>Gail McDaniel</author><pubDate>Tue, 6 Jul 2010 00:00:00 EDT</pubDate></item><item><title>Medicare Reimbursement Rates Increase for Advanced Biologically-Based Fistula Treatment</title><link>http://www.cookmedical.com/newsDetail.do?id=6406</link><description>Bloomington, Ind., July 6, 2010 &amp;#8211; Hospitals nationwide will receive 6 percent higher reimbursement payments for outpatient repair of anal fistulas using Fistula Plug, a device designed specifically to treat this painful and embarrassing disorder of the lower GI tract. According to new Medicare payment schedules effective January 1st, hospital outpatient surgery departments will receive approximately &amp;#36;2,200 per procedure, while freestanding ambulatory surgery centers will be paid about &amp;#36;1,300 on average. The new fee levels come at an opportune time, as fistulas continue to affect tens of thousands of patients each year in North America alone.</description><author>Marsha Lovejoy</author><pubDate>Tue, 6 Jul 2010 00:00:00 EDT</pubDate></item><item><title>Cook Executive Makes Significant Contributions to Health Care, Receives Award of Distinction</title><link>http://www.cookmedical.com/newsDetail.do?id=6404</link><description>Bloomington, Ind., June 28, 2010n &amp;#8212; Cook Group executive Neal Fearnot received the Association for the Advancement of Medical Instrumentation&amp;#39;s (AAMI) highest honor at its annual conference on June 27, 2010 in Tampa, FL. The Laufman&amp;#45;Greatbatch Prize is given annually to an individual or group that has contributed in a unique way to medicine. The award honors those who make a significant global impact to enhance patient care or patient safety. </description><author>Marsha Lovejoy</author><pubDate>Mon, 28 Jun 2010 00:00:00 EDT</pubDate></item><item><title>Endovascular Fusion: The First Multidisciplinary Meeting of its Kind &amp;#8211; Uniting Expertise in Vascular Surgery and Radiology </title><link>http://www.cookmedical.com/newsDetail.do?id=6314</link><description>Warwickshire, 23 June 2010 &amp;#8212; The British Society of Endovascular Therapy (BSET), the British Society of Interventional Radiology (BSIR) and the Vascular Society of Great Britain and Ireland will unite at Endovascular Fusion on the 1st and 2nd of July, in the first meeting of its kind to discuss the latest advances in endovascular therapy. Six, six&amp;#45;month fellowships in aid of the advancement of endovascular surgery will be announced at this meeting. </description><author>Lucie Smith</author><pubDate>Tue, 22 Jun 2010 00:00:00 EDT</pubDate></item><item><title>Cook Medical Files Pre&amp;#45;Market Approval Application for FDA Approval of Zilver&amp;#174; PTX&amp;#174; Drug-Eluting Stent Platform</title><link>http://www.cookmedical.com/newsDetail.do?id=6310</link><description>Bloomington, Ind., June 11, 2010 &amp;#8211; Cook Medical has submitted its Pre&amp;#45;Market Approval &amp;#40;PMA&amp;#41; application to the U.S. Food and Drug Administration &amp;#40;FDA&amp;#41; for the company&amp;#39;s unique polymer&amp;#45;free Zilver&amp;#174; PTX&amp;#174; Drug&amp;#45;Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease &amp;#40;PAD&amp;#41; in the superficial femoral artery &amp;#40;SFA&amp;#41;, Zilver PTX is a self&amp;#45;expanding, highly durable nitinol stent that uses a proprietary, polymer&amp;#45;free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.</description><author>David McCarty</author><pubDate>Fri, 11 Jun 2010 00:00:00 EDT</pubDate></item><item><title>Cook Medical Congratulates the Canadian Interventional Radiology Association on 10 Successful Years</title><link>http://www.cookmedical.com/newsDetail.do?id=6309</link><description>Niagara&amp;#45;on&amp;#45;the&amp;#45;Lake, Ontario, June 10, 2010 &amp;#8212;  Cook Medical congratulates the Canadian Interventional Radiology Association (CIRA) for achieving a significant 10&amp;#45;year milestone in its ongoing efforts to bring awareness to and to further the field of interventional radiology (IR). The organization, founded in 2000 at the Society of Interventional Radiology&amp;#39;s Scientific Meeting, brings together interventional radiologists, residents, fellows, nurses and technologists alike, all of whom share a commitment to advancing a dynamic field consistently on the cutting edge of medicine. To commemorate the occasion, CIRA will host a special event this evening during the 9th Annual Meeting at Queen&amp;#39;s Landing hotel, in Niagara&amp;#45;on&amp;#45;the&amp;#45;Lake, Ontario. </description><author>Marsha Lovejoy</author><pubDate>Thu, 10 Jun 2010 00:00:00 EDT</pubDate></item><item><title>Court Allows Cook Patent Infringement Suit Versus Endologix to Move Forward</title><link>http://www.cookmedical.com/newsDetail.do?id=6308</link><description>Bloomington, Ind., June 4, 2010 &amp;#8212; The United States District Court, Southern District of Indiana, has ruled in favor of Cook Incorporated in its decision to lift the stay on Cook&amp;#39;s patent infringement case against Endologix, Inc. (Nasdaq: ELGX). With this ruling, the case, filed by Cook on October 6, 2009, will now proceed. The complaint claims infringement by Endologix of two Cook patents for endovascular technologies, one of Cook&amp;#39;s leading technology portfolios.</description><author>David McCarty</author><pubDate>Mon, 7 Jun 2010 00:00:00 EDT</pubDate></item><item><title>Cook Medical Honored with Prestigious Health Science Award by the American Urological Association</title><link>http://www.cookmedical.com/newsDetail.do?id=6307</link><description>SAN FRANCISCO &amp;#8211; June 3, 2010&amp;#8211; During the American Urological Association&amp;#8217;s &amp;#40;AUA&amp;#41 annual meeting in San Francisco, medical device innovator and manufacturer Cook Medical was presented with the Association&amp;#8217;s 2010 Health Science Award. The Health Science Award is one of 15 honors presented to individuals and groups who have made significant contributions to the field of medicine, the specialty of urology and the Association.</description><author>Gail McDaniel</author><pubDate>Thu, 3 Jun 2010 00:00:00 EDT</pubDate></item><item><title>New Study Shows Metallic Stent Gives Long&amp;#45;Term Relief from Ureteral Blockage</title><link>http://www.cookmedical.com/newsDetail.do?id=6306</link><description>SAN FRANCISCO &amp;#8211; June 1, 2010 &amp;#8211; A 29&amp;#45;month clinical study demonstrated the long&amp;#45;term success of Cook Medical&amp;#39;s Resonance&amp;#174; Metallic Ureteral Stent in providing drainage for patients with both benign and malignant upper urinary tract obstructions, according to results presented today at the 2010 Annual Meeting of the American Urological Association &amp;#40;AUA&amp;#41;. The findings suggest that metallic stents provide adequate drainage and can be maintained in situ for 12 months without significant encrustation.</description><author>Gail McDaniel</author><pubDate>Tue, 1 Jun 2010 00:00:00 EDT</pubDate></item><item><title>Improved Medical Technology Facilitates Accurate Diagnosis of Kidney Cancers</title><link>http://www.cookmedical.com/newsDetail.do?id=6305</link><description>Bloomington, Ind., May 31, 2010 &amp;#8212; Urologists treating patients with suspicious ureteral or kidney lesions now have a tool to help them more effectively make diagnoses. Cook Medical has introduced the BIGopsy&amp;#174; Backloading Biopsy Forceps, a device designed and engineered to obtain large renal or ureteral tissue specimens up to 4 mm&lt;sup&gt;3&lt;/sup&gt; for cancer diagnosis. The larger sample size helps produce biopsy results without the need for repeat tissue-sampling procedures associated with other biopsy devices. </description><author>Gail McDaniel</author><pubDate>Mon, 31 May 2010 00:00:00 EDT</pubDate></item><item><title>Cook Medical Wins Contract with Novation, Provides 40,000 Health Care Organizations Access to Full Line of Advanced Tissue Repair Technology </title><link>http://www.cookmedical.com/newsDetail.do?id=6213</link><description>Bloomington, Ind., May 12, 2010 &amp;#8212; More than 40,000 U.S. health care providers will gain access to special pricing and terms for an advanced biologic graft for soft tissue repair through a contractual relationship between Cook Medical and Novation, the leading health care supply company for VHA Inc., University HealthSystem Consortium (UHC) and Provista, LLC. Under the agreement, effective April 1, 2010, Cook will supply Novation members with its full line of Biodesign&amp;#174; Advanced Tissue Repair products, intended to treat a wide range of soft tissue defects and related conditions. </description><author>Marsha Lovejoy</author><pubDate>Wed, 12 May 2010 00:00:00 EDT</pubDate></item><item><title>Cook Vows to Protect Its Stent Valve Intellectual Property Portfolio</title><link>http://www.cookmedical.com/newsDetail.do?id=6212</link><description>Bloomington, Ind. &amp;#8212; Cook today announced the first instance German Federal Patent Court found Claim 1 of the German Patent corresponding to European Patent 1 255 510 B3, entitled &amp;#34;Stent Valves&amp;#34; invalid.</description><author>David McCarty</author><pubDate>Fri, 30 Apr 2010 00:00:00 EDT</pubDate></item><item><title>Cook Medical Enrolls First Renal Artery Disease Patient in Groundbreaking Clinical Trial of New Drug-Eluting Stent</title><link>http://www.cookmedical.com/newsDetail.do?id=6208</link><description>Bloomington, Ind. April 12, 2010 &amp;#8211; Patients suffering from blockages of the renal arteries, a condition often leading to high blood pressure and kidney failure, may one day enjoy the clinical benefits of the latest drug&amp;#45;eluting stent technology if a new clinical trial proves the safety and efficacy of a new generation of these devices. Cook Medical has enrolled the first patient in its landmark Formula&amp;#8482; PTX&amp;#174; clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel&amp;#45;eluting, polymer&amp;#45;free stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys. The multi&amp;#45;center, randomised trial plans to enroll 120 patients at sites across Europe and initial results are expected in Q4 of 2010.</description><author>David McCarty</author><pubDate>Wed, 21 Apr 2010 00:00:00 EDT</pubDate></item><item><title>Global Adoption of Cook Medical&amp;#39;s Advanced TEVAR Technology Reflects Physician Support for New Conformable Stent&amp;#45;Graft</title><link>http://www.cookmedical.com/newsDetail.do?id=6210</link><description>Bloomington, Ind., April 13, 2010 &amp;#8211; Physicians have treated more than 1,250 patients worldwide with the Zenith&amp;#174; TX2&amp;#8482; TAA Endovascular Graft with Pro&amp;#45;Form&amp;#8482;, the first&amp;#45;of&amp;#45;its&amp;#45;kind device from Cook Medical designed specifically to repair thoracic aortic aneurysms &amp;#40;TAAs&amp;#41; in anatomies with tight arches as well as conventional cases. Cook&amp;#39;s new Zenith graft, which received FDA approval in May 2009, provides an advanced treatment solution for a life&amp;#45;threatening condition that is diagnosed in 15,000 patients in the U.S. each year. Physicians say they are embracing TX2 with Pro&amp;#45;Form because the graft is designed to enhance treatment in patients whose tight aortic arches pose special difficulties for thoracic endovascular repair &amp;#40;TEVAR&amp;#41; but who cannot tolerate open surgical intervention.</description><author>David McCarty</author><pubDate>Tue, 13 Apr 2010 00:00:00 EDT</pubDate></item><item><title>Cook announces the launch of Coda&amp;#174; Balloon Catheter in Japan</title><link>http://www.cookmedical.com/newsDetail.do?id=6211</link><description>April 13, 2010, Tokyo &amp;#8211; Cook Medical, the world leader in endovascular repair of aortic aneurysms, today announces the availability of the Coda&amp;#174; balloon catheter &amp;#40;Coda&amp;#41; from Cook Medical to the Japanese endovascular market.&amp;#40;approval number 22200BZX00071000&amp;#41;. Coda is an accessory used in endovascular aortic stenting procedures. The new balloon catheter is designed for both optimal expansion of Cook stent grafts and temporary occlusion of large blood vessels. Coda helps to optimize stent graft geometry after implantation of an endograft during endovascular aortic repair &amp;#40;EVAR&amp;#41;. EVAR is a minimally invasive procedure performed in the treatment of aortic aneurysms &amp;#40;abdominal aortic aneurysms: AAA and thoracic aortic aneurysm:TAA&amp;#41;. Cook&amp;#39;s Zenith AAA endovascular graft was the first device of its kind to receive approval in Japan.</description><author>Yumiko Hara</author><pubDate>Tue, 13 Apr 2010 00:00:00 EDT</pubDate></item><item><title>Cook Medical Introduces Next Generation NavAlign&amp;#8482; System for Streamlined IVC Filter Delivery</title><link>http://www.cookmedical.com/newsDetail.do?id=6209</link><description>12 April 2010, LONDON &amp;#8212; European physicians placing inferior vena cava (IVC) filters to prevent patient injury and death from pulmonary embolism (PE) now have access to the newest delivery system from Cook Medical that increases the efficiency and safety of placing these potentially life-saving filters. The new system will be launched in Europe today at the Cook Medical booth at the Charing Cross International Symposium at Imperial College, London.</description><author>David McCarty</author><pubDate>Mon, 12 Apr 2010 00:00:00 EDT</pubDate></item></channel></rss>

